TOS-358

N/A

Report date: 2026/04/23 20:00:25

NME

Base Information

Drug NameTOS-358

Drug Alias NameTOS-358

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionPhosphatidylinositol 3 kinase alpha inhibitors

TargetsPhosphatidylinositol 3 kinase alpha

Therapy Area/IndicationsSolid tumoursBreast Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited StatesSpain

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaN/A

Originator CompaniesTotus Medicines Inc

China Registration ClassN/A

Inactive CompaniesN/A

Active IndicationsSolid tumoursBreast Neoplasms

Inactive IndicationsN/A

ATC CodeN/A